Portfolio – Jan 18, 2022 JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited Read More
Portfolio – Jan 05, 2022 Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China) Read More
Portfolio – Jan 03, 2022 HighLife’s TSMVR Technology successfully used for the first time in China Read More
Portfolio – Dec 09, 2021 Altoida Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups Read More
Portfolio – Dec 07, 2021 Sequana Medical announces positive interim results of SAHARA DESERT trial Read More
Portfolio – Nov 22, 2021 Inositec acquired by Vifor Pharma for its program in first-in-class treatment for progressive vascular calcification Read More
Portfolio – Nov 12, 2021 Oculis announces patient dosing in its diamond study DIAMOND, its first phase 3 study with OCS-01 Read More
Portfolio – Nov 11, 2021 Araris Biotech AG Expands Scientific Advisory Board with Appointment of Dr. Jeff Sharman and Dr. Clive Stanway Read More
Firm – Nov 05, 2021 Susan M. Gasser, advisor to VI Partners, receives honorary doctorate by University of Fribourg Read More
Portfolio – Oct 25, 2021 Altoida and Ionian University Investigate Breakthrough Software Device for Parkinson’s Disease Diagnosis Read More
Portfolio – Oct 18, 2021 Altoida Launches 5-Year Multi-Center Alzheimer’s Study with Eisai and Ionian University Read More
Portfolio – Oct 13, 2021 Acodis accelerates its growth with a CHF 2.5m financing led by VI Partners Read More
Portfolio – Oct 07, 2021 Oculis Appoints Dr. Joanne Chang as Global Chief Medical Officer and Opens Hong Kong Office to broaden its footprint Read More
Portfolio – Sep 07, 2021 VI Partners increases their investment in existing portfolio company Ledgy, welcoming new lead investor Sequoia Capital in the US$10m Series A round Read More
Portfolio – Aug 16, 2021 JenaValve Receives IDE Approval to Initiate The ALIGN-AR Pivotal PMA Trial Read More
Portfolio – Aug 05, 2021 Altoida Awarded FDA Breakthrough Designation for Development of World’s First Precision Neurology Device for Prediction of Alzheimer’s Disease Read More
Portfolio – Jul 08, 2021 Altoida Secures Funding and Research Partnership with Eisai Innovation to Accelerate Work Towards Predictive Dementia Diagnostics Read More
Portfolio – Jul 08, 2021 Xeltis initiates first-ever pivotal trial of a synthetic restorative pulmonary heart valve Read More
Portfolio – Jul 01, 2021 Sequana Medical announces positive results from second interim analysis of North American pivotal alfapump study – POSEIDON Read More
Portfolio – May 20, 2021 JenaValve Technology Receives CE Mark for its TrilogyTM TAVI System for the Treatment of Aortic Regurgitation and Aortic Stenosis Read More
Portfolio – May 06, 2021 Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform Read More
Portfolio – May 05, 2021 VI Partners invests in late-stage biopharmaceutical company Oculis Read More
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)
)